Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Johnson & Johnson, liquidity ratios

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Current ratio 1.16 0.99 1.35 1.21 1.26
Quick ratio 0.82 0.71 1.04 0.91 0.94
Cash ratio 0.50 0.42 0.70 0.59 0.54

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson current ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson quick ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson cash ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.

Current Ratio

Johnson & Johnson, current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Selected Financial Data (US$ in millions)
Current assets 53,495 55,294 60,979 51,237 45,274
Current liabilities 46,282 55,802 45,226 42,493 35,964
Liquidity Ratio
Current ratio1 1.16 0.99 1.35 1.21 1.26
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.87 0.96 0.79 0.84 3.18
Amgen Inc. 1.65 1.41 1.59 1.81 1.44
Bristol-Myers Squibb Co. 1.43 1.25 1.52 1.58 1.60
Eli Lilly & Co. 0.94 1.05 1.23 1.40 1.16
Gilead Sciences Inc. 1.43 1.29 1.27 1.40 3.10
Merck & Co. Inc. 1.25 1.47 1.27 1.02 1.24
Pfizer Inc. 0.91 1.22 1.40 1.35 0.88
Regeneron Pharmaceuticals Inc. 5.69 5.06 3.56 3.63 3.67
Thermo Fisher Scientific Inc. 1.75 1.48 1.50 2.13 1.92
Vertex Pharmaceuticals Inc. 3.99 4.83 4.46 4.33 3.61
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.26 1.28 1.36 1.36 1.56
Current Ratio, Industry
Health Care 1.15 1.17 1.22 1.22 1.34

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

1 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 53,495 ÷ 46,282 = 1.16

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson current ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.

Quick Ratio

Johnson & Johnson, quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 21,859 14,127 14,487 13,985 17,305
Marketable securities 1,068 9,392 17,121 11,200 1,982
Accounts receivable trade, less allowances 14,873 16,160 15,283 13,576 14,481
Total quick assets 37,800 39,679 46,891 38,761 33,768
 
Current liabilities 46,282 55,802 45,226 42,493 35,964
Liquidity Ratio
Quick ratio1 0.82 0.71 1.04 0.91 0.94
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.63 0.69 0.56 0.60 2.91
Amgen Inc. 0.99 0.95 1.06 1.30 1.01
Bristol-Myers Squibb Co. 1.04 0.87 1.20 1.28 1.26
Eli Lilly & Co. 0.52 0.63 0.80 0.85 0.68
Gilead Sciences Inc. 1.06 0.99 0.95 1.08 2.86
Merck & Co. Inc. 0.68 0.93 0.73 0.58 0.78
Pfizer Inc. 0.50 0.80 1.00 0.78 0.50
Regeneron Pharmaceuticals Inc. 4.82 4.16 2.98 2.86 2.81
Thermo Fisher Scientific Inc. 1.27 1.06 1.00 1.63 1.19
Vertex Pharmaceuticals Inc. 3.60 4.46 4.04 4.02 3.33
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.84 0.90 0.98 0.96 1.18
Quick Ratio, Industry
Health Care 0.84 0.87 0.90 0.91 1.01

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

1 2023 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 37,800 ÷ 46,282 = 0.82

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson quick ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.

Cash Ratio

Johnson & Johnson, cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 21,859 14,127 14,487 13,985 17,305
Marketable securities 1,068 9,392 17,121 11,200 1,982
Total cash assets 22,927 23,519 31,608 25,185 19,287
 
Current liabilities 46,282 55,802 45,226 42,493 35,964
Liquidity Ratio
Cash ratio1 0.50 0.42 0.70 0.59 0.54
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.34 0.31 0.28 0.30 2.56
Amgen Inc. 0.60 0.59 0.66 0.91 0.69
Bristol-Myers Squibb Co. 0.55 0.42 0.78 0.83 0.84
Eli Lilly & Co. 0.11 0.13 0.26 0.29 0.21
Gilead Sciences Inc. 0.64 0.57 0.56 0.65 2.50
Merck & Co. Inc. 0.28 0.54 0.34 0.30 0.47
Pfizer Inc. 0.27 0.54 0.73 0.47 0.26
Regeneron Pharmaceuticals Inc. 3.17 2.46 1.45 1.33 1.53
Thermo Fisher Scientific Inc. 0.58 0.50 0.33 1.00 0.39
Vertex Pharmaceuticals Inc. 3.16 3.93 3.51 3.55 2.85
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.46 0.51 0.59 0.58 0.81
Cash Ratio, Industry
Health Care 0.44 0.49 0.52 0.54 0.64

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

1 2023 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 22,927 ÷ 46,282 = 0.50

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson cash ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.